Abstract
Background:The risk of tuberculosis (TB) has decreased in biologic disease modifying anti-rheumatic drugs (bDMARDs) treated rheumatoid arthritis (RA) patients, but remains unaltered 4-fold increased in bio-naïve RA patients compared to...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have